Hi @disaster
i respectfully disagree. I dont see any information at all that our efs endpoint is 12 months post last implanted valve.
I think because many are waiting for 12 month data to ge released from Georgia, many are assuming the fda efs will also need to be 12 months. I disagree with that. I think 2023 is a real possibility for fda approval.
AVR milestones, page-41
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.35 |
Change
0.040(0.22%) |
Mkt cap ! $353.4M | |||
| Open | High | Low | Value | Volume |
| $19.00 | $19.00 | $18.13 | $69.15K | 3.766K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 383 | $18.13 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.50 | 1000 | 1 |
View Market Depth
| Last trade - 15.59pm 02/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |